Prostatitis syndromes and benign prostatic hyperplasia

Collins, 1997, How common is prostatitis? A national survey of physician visits, J Urol, 157, 243 Moon, 1997, Questionnaire survey of urologists and primary care physicians' diagnostic and treatment practices for prostatitis, Urology, 50, 543, 10.1016/S0090-4295(97)00308-7 Roberts, 1997, A community-based study on the prevalence of prostatitis, J Urol, 157, 242 Drach, 1978, Classification of benign disease associated with prostatic pain: Prostatitis or prostatodynia?, J Urol, 120, 266, 10.1016/S0022-5347(17)57135-9 Chronic Prostatitis Workshop, 1995 Meares, 1987, Acute and chronic prostatitis: Diagnosis and treatment, Infect Dis Clin North Am, 1, 855, 10.1016/S0891-5520(20)30153-7 Meares, 1998, Prostatitis and related disorders, vol 1, 615 Bruce, 1981, The role of chlamydiae in genitourinary disease, J Urol, 126, 625, 10.1016/S0022-5347(17)54660-1 Brunner, 1983, Studies of the role of Ureaplasma urealyticum and Mycoplasma hominis in prostatitis, J Infect Dis, 147, 807, 10.1093/infdis/147.5.807 Poletti, 1985, Isolation of Chlamydia trachomatis from the prostatic cells in patients affected by nonacute abacterial prostatitis, J Urol, 134, 691, 10.1016/S0022-5347(17)47387-3 Weidner, 1991, Chronic prostatitis: A thorough search for etiologically involved microorganisms in 1,461 patients, Infection, 19, 119, 10.1007/BF01643680 Berger, 1997, Bacteria in the prostate tissue of men with idiopathic prostatic inflammation, J Urol, 157, 863, 10.1016/S0022-5347(01)65066-3 Shortliffe, 1989, Measurement of urinary antibodies to crude bacterial antigen in patients with chronic bacterial prostatitis, J Urol, 141, 632, 10.1016/S0022-5347(17)40921-9 Kirby, 1982, Intra-prostatic urinary reflux: An aetiological factor in abacterial prostatitis, Br J Urol, 54, 729, 10.1111/j.1464-410X.1982.tb13635.x Ramirez, 1980, A crystallographic study of prostatic calculi, J Urol, 124, 840, 10.1016/S0022-5347(17)55691-8 Meares, 1968, Bacteriologic localization patterns in bacterial prostatitis and urethritis, Invest Urol, 5, 492 Nickel, 1995, A practical approach to the management of prostatitis, Techn Urol, 1, 162 Nigro, 1997, Diagnosis and treatment of prostatitis in Canada, J Urol, 157, 241 Nickel, 1997, The pre and post massage test (PPMT): A simple screen for prostatitis, Tech Urol, 3, 38 Young, 1978, Treatment of Salmonella prostatitis with trimethoprim-sulfamethoxazole, South Med J, 71, 742, 10.1097/00007611-197806000-00039 Ristuccia, 1982, Current concepts in antimicrobial therapy of prostatitis, Urology, 20, 338, 10.1016/0090-4295(82)90660-4 Naber, 1989, Use of quinolones in urinary tract infections and prostatitis, Rev Infect Dis, 11, 1321, 10.1093/clinids/11.Supplement_5.S1321 Weinberger, 1988, Prostatic abscess in the antibiotic era, Rev Infect Dis, 10, 239, 10.1093/clinids/10.2.239 Dajani, 1968, Prostatic abscess, Br J Urol, 40, 736, 10.1111/j.1464-410X.1968.tb11875.x Sargent, 1931, Prostatic abscess: Clinical study of 42 cases, Am J Surg, 11, 334, 10.1016/S0002-9610(31)90666-1 Lee, 1986, Sonographic demonstration of prostatic abscess, J Ultrasound Med, 5, 101, 10.7863/jum.1986.5.2.101 Pfau, 1986, Prostatitis: A continuing enigma, Urol Clin N Am, 13, 695, 10.1016/S0094-0143(21)00273-1 Doble, 1994, Chronic prostatitis, Br J Urol, 74, 537, 10.1111/j.1464-410X.1994.tb09180.x Stamey, 1973, The concentration of trimethoprim in prostatic fluid: Nonionic diffusion or active transport?, J Infect Dis, 128, 686, 10.1093/infdis/128.Supplement_3.S686 Nickel, 1993, Bacterial localization in antibiotic refractory chronic bacterial prostatitis, Prostate, 23, 107, 10.1002/pros.2990230204 Krieger, 1991, Comprehensive evaluation and treatment of 75 men referred to chronic prostatitis clinic, Urology, 38, 11, 10.1016/0090-4295(91)80004-Q Meares, 1980, Prostatitis syndromes: New perspectives about old woes, J Urol, 123, 141, 10.1016/S0022-5347(17)55828-0 Echols, 1995, Efficacy and safety of ciprofloxacin for chronic bacterial prostatitis, Infect Med, 12, 283 Weidner, 1992, Refractory chronic bacterial prostatitis: A re-evaluation of ciprofloxacin treatment after a median follow-up of 30 months, J Urol, 146, 350, 10.1016/S0022-5347(17)37791-1 Fair, 1976, The prostatic antibacterial factor: Identity and significance, vol 6, 340 Partin, 1998, The molecular biology, endocrinology, and physiology of the prostate and seminal vesicles, vol 2, 1381 Meares, 1986, Chronic bacterial prostatitis: Role of transurethral prostatectomy (TURP) in therapy, 193 Meares, 1986, Prostatodynia: Clinical findings and rationale for treatment, 207 Person, 1996, Evidence for a mechanistic association between nonbacterial prostatitis and levels of urate and creatinine in expressed prostatic secretions, J Urol, 155, 958, 10.1016/S0022-5347(01)66357-2 Nickel, 1998, Effective office management of chronic prostatitis, Urol Clin North Am, 25, 677, 10.1016/S0094-0143(05)70056-2 Guess, 1990, The cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia, Prostate, 17, 241, 10.1002/pros.2990170308 Kortt, 1996, The economics of benign prostatic hyperplasia treatment: A literature review, Clin Ther, 18, 1227, 10.1016/S0149-2918(96)80078-6 Abrams, 1994, New words for old: Lower urinary tract symptoms for “prostatism”, BMJ, 308, 929, 10.1136/bmj.308.6934.929 1993 McConnell, 1994, Benign prostatic hyperplasia: Diagnosis and Treatment Clinical Guidelines, Number 8 Denis, 1998, Recommendations of the International Consensus Committee: The evaluation and treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction, 669 Roehrborn, 1986, The role of transabdominal ultrasound in the preoperative evaluation of patients with benign prostatic hypertrophy, J Urol, 135, 1190, 10.1016/S0022-5347(17)46032-0 McConnell, 1998, Epidemiology, etiology, pathophysiology, and diagnosis of benign prostatic hyperplasia, vol 2, 1429 Mebust, 1989, Transurethral prostatectomy: Immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients, J Urol, 141, 242, 10.1016/S0022-5347(17)40731-2 Melchior, 1974, Transurethral prostatectomy in the azotemic patient, J Urol, 112, 643, 10.1016/S0022-5347(17)59818-3 Ornstein, 1997, The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate, J Urol, 157, 880, 10.1016/S0022-5347(01)65072-9 Holtgrewe, 1996, The economics of prostate cancer, 399 Barry, 1992, The American Urological Association Symptom Index for benign prostatic hyperplasia, J Urol, 148, 1549, 10.1016/S0022-5347(17)36966-5 Abrams, 1993, The objective evaluation of bladder outlet obstruction (urodynamics), 115 Feneley, 1996, Reproducibility of uroflow measurement: Experience during a double blind, placebo-controlled study of doxazosin in benign prostatic hyperplasia, Urology, 47, 658, 10.1016/S0090-4295(96)00014-3 Reynard, 1996, The value of multiple free flow studies in men with lower urinary tract symptoms, Br J Urol, 77, 813, 10.1046/j.1464-410X.1996.00097.x McConnell, 1994, Why pressure flow studies should be optional and not mandatory for evaluating men with benign prostatic hyperplasia, Urology, 44, 156, 10.1016/S0090-4295(94)80120-7 Holtgrewe, 1998, The medical management of lower urinary tract symptoms and benign prostatic hyperplasia, Urol Clin North Am, 25, 555, 10.1016/S0094-0143(05)70047-1 Roehrborn, 1991, Is routine imaging of the urinary tract prior to prostatectomy a justifiable practice?, J Urol, 145, 266A Narayan, 1998, Overview of alpha-blocker therapy for benign prostatic hyperplasia, Urology, 51, 38, 10.1016/S0090-4295(98)00054-5 Roehrborn, 1996, Safety and efficacy of doxazosin in benign prostatic hyperplasia: A pooled analysis of three double blind, placebo-controlled studies, Urology, 48, 406, 10.1016/S0090-4295(96)00208-7 Lepor, 1997, Effect of terazosin on prostatism in men with normal and abnormal peak urinary flow rates, Urology, 49, 476, 10.1016/S0090-4295(96)00504-3 Lepor, 1995, Long term efficacy and safety of terazosin in patients with benign prostatic hyperplasia: Terazosin Research Group, Urology, 45, 406, 10.1016/S0090-4295(99)80008-9 Lepor, 1997, BPH—a glimpse into the future, AUA News, 2, 12 Beduschi, 1998, Alpha-blockade therapy for benign prostatic hyperplasia: From a nonselective to a more selective alpha-1A-adrenergic antagonist, Urology, 51, 861, 10.1016/S0090-4295(98)00140-X Lowe, 1997, Coadministration of tamsulosin and three antihypertensive agents in patients with benign prostatic hyperplasia: Pharmacodynamic effect, Clin Ther, 19, 730, 10.1016/S0149-2918(97)80097-5 Brooks, 1986, Prostatic effects induced in dogs by chronic or acute oral administration of 5-alpha-reductase inhibitors, Prostate, 9, 65, 10.1002/pros.2990090110 Andersen, 1995, Can finasteride reverse the progress of benign prostatic hyperplasia? A two-year placebo-controlled study. The Scandinavian BPH Study Group, Urology, 46, 631, 10.1016/S0090-4295(99)80291-X Nickel, 1996, Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: Results of a 2 year randomized controlled trial (The PROSPECT Study). Proscar Safety Plans Efficacy Canadian Two Year Study, Can Med Assoc J, 155, 1251 Tewari, 1995, Transition zone volume and transition zone ratio: Predictor of uroflow response to finasteride therapy in benign prostatic hyperplasia patients, Urology, 45, 258, 10.1016/0090-4295(95)80015-8 Boyle, 1996, Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials, Urology, 48, 398, 10.1016/S0090-4295(96)00353-6 McConnell, 1998, Finasteride decreases the incidence of BPH related surgery and acute urinary retention, N Engl J Med, 338, 557, 10.1056/NEJM199802263380901 Potter, 1999, Clinical utility, benefits, and limitations of percent free PSA, Contemp Urol, 11, 15 Wilt, 1998, Saw palmetto extracts for treatment of benign prostatic hyperplasia: A systematic review, JAMA, 280, 1604, 10.1001/jama.280.18.1604 Oesterling, 1998, Retropubic and suprapubic prostatectomy, vol 2, 1529 Jepsen, 1998, Recent developments in the surgical management of benign prostatic hyperplasia, Urology, 51, 23, 10.1016/S0090-4295(98)00052-1 Stutzman, 1996, Suprapubic Prostatectomy, 532 Wasson, 1995, Comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia, N Engl J Med, 332, 75, 10.1056/NEJM199501123320202 Orandi, 1973, Transurethral incision of the prostate, J Urol, 110, 229, 10.1016/S0022-5347(17)60172-1 Orandi, 1987, Transurethral incision of the prostate compared with transurethral resection of the prostate in 132 matching cases, J Urol, 138, 810, 10.1016/S0022-5347(17)43382-9 Christensen, 1990, Transurethral resection versus transurethral incision of the prostate, a prospective randomized study, Urol Clin North Am, 17, 621, 10.1016/S0094-0143(21)00975-7 Katz, 1990, Transurethral incision of the bladder neck and prostate, J Urol, 144, 694, 10.1016/S0022-5347(17)39557-5 Bruskewitz, 1990, Critical evaluation of transurethral resection and incision of the prostate, Prostate, 3, 27, 10.1002/pros.2990170504 Dorflinger, 1992, Transurethral prostatectomy compared with incision of the prostate in the treatment of prostatism caused by small benign prostate glands, Scand J Urol Nephrol, 26, 333, 10.3109/00365599209181222 Mebust, 1998, Transurethral surgery, vol 2, 1511 Kaplan, 1995, Transurethral electrovaporization of the prostate: A novel method for treating men with benign prostatic hyperplasia, Urology, 45, 566, 10.1016/S0090-4295(99)80044-2 McCullough, 1998, Minimally invasive treatment of benign prostatic hyperplasia, vol 2, 1479 Harewood, 1995, Transurethral needle ablation of the prostate (TUNA): Clinical results and ultrasound, endoscopic, and histologic findings in a pilot study of patients in urinary retention, J Endourol, 101, 33 Schulman, 1995, Transurethral needle ablation of the prostate for treatment of benign prostatic hyperplasia: Early clinical experience, Urology, 45, 28, 10.1016/S0090-4295(95)96260-3 Kaplan, 1998, Minimally invasive alternative therapeutic options for lower urinary tract symptoms, Urology, 51, 32, 10.1016/S0090-4295(98)00053-3 Beduschi, 1998, Transurethral needle ablation of the prostate: A minimally invasive treatment for symptomatic benign prostatic hyperplasia, 73, 696 Muschter, 1995, Technique and results of interstitial laser coagulation, World J Urol, 13, 109, 10.1007/BF00183624 Kabalin, 1998, Application of the holmium: YAG laser for prostatectomy, J Clin Laser Med Surg, 16, 21, 10.1089/clm.1998.16.21 Abbou, 1995, Transrectal and transurethral hyperthermia versus sham treatment in benign prostatic hyperplasia: A double-blind randomized multicentre clinical trial, Br J Urol, 76, 619, 10.1111/j.1464-410X.1995.tb07789.x Ramsey, 1997, Novel transurethral microwave thermal ablation system to treat benign prostatic hyperplasia: Results of a prospective multicentre clinical trial, J Urol, 158, 112, 10.1097/00005392-199707000-00032 Mayer, 1997, US multicenter study results of a new high temperature microwave system for BPH show improvement in patient symptoms and flow rates without compromise in morbidity and anesthetic needs, J Urol, 157, 95 Ahmed, 1997, Transurethral microwave thermotherapy (Prostatron version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: A randomized, controlled, parallel study, Br J Urol, 79, 181, 10.1046/j.1464-410X.1997.02667.x d'Ancona, 1997, Thermotherapy versus transurethral resection for benign prostatic hyperplasia, J Urol, 158, 120, 10.1097/00005392-199707000-00035 Ramsey, 1998, Office treatment of benign prostatic hyperplasia, Urol Clin North Am, 25, 571, 10.1016/S0094-0143(05)70048-3 Kaplan, 1997, Prostatic endoprosthetics, 331 Harmon, 1996, Transurethral enzymatic ablation of the prostate canine model, Urology, 48, 229, 10.1016/S0090-4295(96)00082-9 Darson, 1998, Transurethral enzyme injection—future management of benign prostatic hyperplasia, 73, 908 Djavan, 1998, Transurethral microwave thermotherapy: What role should it play versus medical management in the treatment of benign prostatic hyperplasia, Urology, 52, 935, 10.1016/S0090-4295(98)00471-3